EMA CHMP recommends approval for Novartis' PNH treatment
Novartis has received a positive EMA CHMP recommendation for granting approval for Fabhalta (iptacopan) to treat paroxysmal nocturnal haemoglobinuria.
Patrick Horber News Today : Breaking News, Live Updates & Top Stories | Vimarsana
Stay updated with breaking news from Patrick Horber. Get real-time updates on events, politics, business, and more. Visit us for reliable news and exclusive interviews.
Top News In Patrick Horber Today - Breaking & Trending Today
Abbvie executive Patrick Horber appointed as Novartis's President, International
Basel: Novartis has announced that Marie-France Tschudin, President, Innovative Medicines International and Chief Commercial Officer, has decided to leave the company and will step down from the...
Source: medicaldialogues.in
Novartis names new board member after international boss steps down
Novartis has appointed AbbVie executive Patrick Horber to its executive committee, the Swiss pharmaceuticals maker said on Wednesday, after Chief Commercial Officer Marie-France Tschudin stepped down. Horber, currently Senior Vice President and President, Immunology at AbbVie has been appointed as President, International, effective later this year. Tschudin, President, Innovative Medicines International and Chief Commercial Officer, has decided to leave Novartis after seven years with the company and will step down from the executive committee, effective September 15.
Source: yahoo.com
Novartis: Novartis names new board member after international boss steps down
Novartis has appointed AbbVie executive Patrick Horber to its executive committee, the Swiss pharmaceuticals maker said on Wednesday, after Chief Commercial Officer Marie-France Tschudin stepped down. Horber, currently Senior Vice President and President, Immunology at AbbVie has been appointed as President, International, effective later this year.
Source: indiatimes.com
Novartis hires AbbVie exec Patrick Horber as international chief
Marie-France Tschudin will step down in mid-September from her role as Novartis’ president of Innovative Medicines International and chief commercial officer.
Source: mmm-online.com